Live Chat

Perdagangan Gilead GILD

Jual
 Beli

Gilead diagram langsung

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) instr__open Tinggi Rendah

Berita

Info

Spread

0.52

Spread (%)

0.6156 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Jumat

13:31 - 19:59

Senin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Kamis

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

107243429888

instr__shares_outstand

1244989952

instr__earnings_date

2013-01-28

Hasil Div

2024-09-27

Tanggal Non-Dividen

2024-09-13

Proyeksi tingkat dividen tahunan

3.08

Proyeksi hasil dividen tahunan

0.0358

instr__eps

0.82

instrument_learn_more

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

related_instruments

Aset
Jual
Beli
Ubah (%)

Lakukan Trading

Lakukan Trading

Lakukan Trading

Lakukan Trading
view_all_instruments

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

Wall Street's leading indices notch fresh records ahead of US inflation data release later today

Kamis, 10 Oktober 2024

Wall St. soars to new highs ahead of US inflation report

Rabu, 9 Oktober 2024

Hang Seng index surges, breaking 21,000 mark

Rabu, 9 Oktober 2024

Dow Jones index today: Dow Hit Record Closing Highs

Rabu, 9 Oktober 2024

Nvidia stock surges 4% in Tuesday, notching its fifth straight day of gains

Lihat semua berita
Live Chat